Aloe Vera

Metadata

Approved Indications

Commission E (Germany)

• Approved for: Constipation (oral aloe latex only)
• NOT approved for topical wound healing or skin care
• The Commission E monograph addresses Aloe (dried latex/juice), not the leaf gel

ESCOP (European Scientific Cooperative on Phytotherapy)

• Monograph addresses aloe dried juice for constipation
• No specific monograph for aloe gel topical wound healing [NEEDS-RESEARCH]

EMA/HMPC (European Medicines Agency)

• Monograph exists for: “Aloe barbadensis Mill. and Aloe (various species, mainly Aloe ferox Mill.), folii succus siccatus” — addressing the dried latex for constipation
• No EMA monograph for aloe vera gel for topical wound healing
• The EMA has noted commercial aloe creams/gels used externally for radiation-induced dermatitis

Agreement/Disagreement Between Bodies

• All three European regulatory bodies agree on approving aloe for constipation (latex) while providing no formal monograph for topical gel wound healing
• This represents a significant regulatory gap — the most widely used topical application of aloe globally has no formal European phytotherapy monograph
• The distinction between aloe latex (anthraquinone-containing laxative) and aloe gel (polysaccharide-containing wound healer) is critical and often confused

Conditions Treated

Primary (Evidence-Supported, No Formal Monograph)

• Partial-thickness (second-degree) burns
• Minor burns and sunburn
• Radiation dermatitis (as supportive care)

Secondary (Clinical/Traditional Use)

• Wound healing (general)
• Skin moisturization and protection
• Mild skin inflammations
• Psoriasis [PRELIMINARY]
• Frostbite [PRELIMINARY]
• Oral mucositis

Mechanism of Action

Key Active Compounds (Gel)

• Acemannan (acetylated glucomannan) — primary active polysaccharide; immunomodulatory, wound-healing
• Glucomannan — growth factor interaction, fibroblast stimulation
• Gibberellin — growth hormone; interacts with growth factor receptors
• Mannose-6-phosphate — growth factor receptor binding
• Vitamins: A, C, E (antioxidant)
• Enzymes: Bradykinase (anti-inflammatory), superoxide dismutase
• Sterols: Lupeol, campesterol (anti-inflammatory)

Mechanisms

1. Macrophage activation: Acemannan activates macrophages, inducing release of IL-1, IL-6, TNF-alpha — promoting fibroblast proliferation [Source: PMC10385217]
2. Growth factor stimulation: Glucomannan and gibberellin interact with growth factor receptors on fibroblasts, stimulating collagen synthesis [Source: PMC2763764]
3. Angiogenesis promotion: Acemannan stimulates VEGF expression
4. Moist wound environment: Gel maintains wound hydration, promoting optimal healing conditions
5. Anti-inflammatory: Bradykinase and sterols reduce inflammation
6. Immunomodulation: Acemannan induces IL-12 release, activating NK cells and T cell proliferation

Critical Distinction: Gel vs. Latex

• Aloe gel (inner leaf parenchyma): Polysaccharide-rich, wound-healing
• Aloe latex (yellow exudate, pericyclic tubules): Anthraquinone-rich (aloin/barbaloin), laxative — completely different pharmacological profile
• Product contamination with latex compounds is a quality concern

Clinical Evidence Summary

Meta-Analyses

Systematic Reviews

• Dat et al. (2012): Cochrane-style review for acute and chronic wounds. Concluded: “currently an absence of high quality clinical trial evidence to support the use of Aloe vera topical agents or dressings as treatments for acute and chronic wounds”
• Hekmatpou et al. (2019): Systematic review of aloe vera for prevention and healing of skin wounds. Found positive effects but called for more rigorous studies.

Evidence Assessment

• Burns (second-degree): Most consistent positive evidence; two meta-analyses show statistically significant faster healing
• Chronic wounds: Divergent results; insufficient evidence
• Radiation dermatitis: Mixed results
• General wound healing: Positive signal but evidence is limited by small, heterogeneous, low-quality trials
• Overall: Promising preclinical evidence and positive meta-analyses for burns; but overall trial quality is low and product standardization is poor [NEEDS-RESEARCH for high-quality confirmatory RCTs]

European vs US/Anglophone Consensus

Notable regulatory anomaly: Aloe vera is the only herb in this knowledge base where the US/Anglophone tradition shows GREATER clinical acceptance than the European evidence-based phytotherapy tradition, which has essentially declined to endorse it for topical use.

Safety Profile

Contraindications (Topical Gel)

• Known hypersensitivity to Aloe or Asphodelaceae
• Not recommended on deep surgical wounds without medical supervision
• Oral latex: Contraindicated in Crohn’s disease, ileus, appendicitis, pregnancy, lactation, children under 12

Drug Interactions (Topical)

• No significant drug interactions reported for topical gel use
• Oral latex: Potassium depletion risk — interaction with cardiac glycosides, antiarrhythmics, loop/thiazide diuretics, corticosteroids

Side Effects (Topical)

• Rare contact dermatitis
• Possible irritation if product is contaminated with aloe latex
• Generally very well tolerated topically
• Some reports of delayed healing in deep surgical wounds (conflicting data)

Pregnancy/Lactation

• Topical gel: Generally considered safe
• Oral latex: Contraindicated in pregnancy and lactation

Clinical Dosage

Topical Preparations

Product Quality Concerns

• Many commercial “aloe vera” products contain minimal actual aloe
• International Aloe Science Council (IASC) certification indicates quality standards
• Inner gel should be separated from latex carefully during processing
• Acemannan content is the best marker for gel quality

Key Commercial Products (Europe)

• Limited standardized pharmaceutical products compared to other herbs in this series
• Primarily available as cosmetic-grade products
• Some wound care products containing aloe vera gel exist (e.g., aloe vera hydrogels)

Sources

• EMA Assessment Report on Aloe barbadensis Mill. / Aloe species, folii succus siccatus
• Maenthaisong et al. (2007). Aloe vera for burn wound healing: Systematic review. Burns. PMID: 17499928
• Burusapat et al. (2022). Second-degree burns and aloe vera: Meta-analysis. PMID: 36264753
• Dat et al. (2012). Cochrane review: Aloe vera for acute/chronic wounds. PMC9943919
• Hekmatpou et al. (2019). Aloe vera clinical trials for skin wound healing. PMC6330525
• PMC10385217: Acemannan from basic studies to clinical application
• PMC2763764: Aloe vera: A short review
• Restorativemedicine.org: Aloe vera monograph

Connections

• Contrast with Calendula and Comfrey which have strong European regulatory endorsement
• Burns indication overlaps with St Johns Wort Oil (first-degree burns)
• Product quality concerns parallel Tea Tree (oxidation) and Witch Hazel (extract vs. distillate)